News round-up by DDW’s Reece Armstrong for 1-5 August
New research could pave the way to the earlier diagnosis of brain tumours through the development of a simple blood test for glioblastomas.
The International Finance Corporation (IFC) is investing $30 million in the pharmaceutical company Laboratorios Siegfried to help provide lower-income populations across the Latin America and the Caribbean (LAC) regions with better access to high-quality and affordable healthcare products.
An international team of researchers has won £30 million for its work in developing a potential cure for inherited heart muscle conditions in young people.
In a presentation at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of technology revealed insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research.
For the first time, a series of short seminars focused on automation will be available to visitors of Drug Discovery 2022 (4-5 Oct, London, UK).